Vistagen reports topline phase 2 results for av-101 as an adjunctive treatment of major depressive disorder
First, the specific anemia type stated in the provider's own assessment language, not inferred from lab values alone
Nicotinamide (niacinamide) does not cause flushing and has fewer side effects, with nausea and liver toxicity reported only at very high intakes ~3 g/day)
These novel therapies have often exceeded expectations by demonstrating beneficial effects that extend to complications that were not the primary focus of their development
Serious but rare complications: Hypokalaemia: Rapid B12 replacement in severely deficient patients can precipitate potassium depletion during haematopoietic recovery, potentially causing cardiac arrhythmias
HDAC 1, 3, 5, and 7 are expressed in neural stem cells